-+ 0.00%
-+ 0.00%
-+ 0.00%

Palvella Therapeutics CSO Jeff Martini presents at FDA drug repurposing workshop

PUBT·07/30/2026 11:46:10
Listen to the news
Palvella Therapeutics CSO Jeff Martini presents at FDA drug repurposing workshop
  • Palvella Therapeutics will attend an FDA public workshop on drug repurposing on Aug. 5, 2026, in Washington, D.C.
  • Chief Scientific Officer Jeffrey Martini is scheduled to deliver public comments on evidence standards, policy barriers, and regulatory pathways for repurposed therapies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palvella Therapeutics Inc. published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.